Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +4 vs. previous quarter
- 20
- 13F valueReported value at the end of Q2 2026
- $6.37M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SNTI, Q2 2026
No superinvestor reported holding SNTI at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Senti Biosciences Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2025 (view filing) | Feb 4-6 | 2 days | Lu Timothy KCEO | SSale | −4.47K | $4.11 | −$18.3K | −5.2%82.1K after | 2 lots |
| Feb 6, 2025 (view filing) | Feb 4-6 | 2 days | Rajangam KanyaPres. & Chief Med. & Dev. Off. | SSale | −1.48K | $4.11 | −$6.07K | −14.6%8.62K after | 2 lots |
| Dec 11, 2024 (view filing)7:38 PM ET | Dec 9 | 2 days | Bayer Aktiengesellschaft and 3 others10% Owner | PPurchase | +5.55M | – | – | –3.33M after | Derivative2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Senti Biosciences Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 3,775,615 | $4.15M | 0.26% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 888,000 | $976.8K | 0.06% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 537,504 | $591.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 187,065 | $205.8K | 0.00% | −19,978−9.6% | Reduced |
| Citadel Advisors LLC | 107,100 | $117.8K | 0.00% | +107,100 | New |
| Vanguard Fiduciary Trust Co | 91,193 | $100.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 52,530 | $57.8K | 0.00% | +52,530 | New |
| Menlo Ventures Management, L.P. | 35,737 | $39.3K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 32,154 | $35.4K | 0.00% | +15,376+91.6% | Added |
| XTX Topco Ltd | 23,610 | $26.0K | 0.00% | +6,333+36.7% | Added |